110 related articles for article (PubMed ID: 2758032)
1. DNA damage and cytotoxicity of nitracrine in cultured HeLa cells.
Szmigiero L; Studzian K
Biochim Biophys Acta; 1989 Aug; 1008(3):339-45. PubMed ID: 2758032
[TBL] [Abstract][Full Text] [Related]
2. DNA damage in HeLa s3 cells by an antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.
Woynarowski JM; Bartoszek A; Konopa J
Chem Biol Interact; 1984 May; 49(3):311-28. PubMed ID: 6722943
[TBL] [Abstract][Full Text] [Related]
3. Are lethal effects of nitracrine on L5178Y cell sublines associated with DNA-protein crosslinks?
Walicka M; Szmigiero L; Ciesielska E; Gradzka I
Biochem Pharmacol; 1993 Aug; 46(4):615-20. PubMed ID: 8363635
[TBL] [Abstract][Full Text] [Related]
4. The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridines.
Konopa J; Pawlak JW; Pawlak K
Chem Biol Interact; 1983 Feb; 43(2):175-97. PubMed ID: 6402315
[TBL] [Abstract][Full Text] [Related]
5. DNA-protein cross-linking induced by nitracrine in two strains of mouse lymphoma L5178Y cells.
Ciesielska E; Walicka M; Pastwa E; Szmigiero L
Acta Biochim Pol; 1992; 39(1):53-7. PubMed ID: 1441836
[No Abstract] [Full Text] [Related]
6. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.
Woynarowski JM; McNamee H; Szmigiero L; Beerman TA; Konopa J
Biochem Pharmacol; 1989 Nov; 38(22):4095-101. PubMed ID: 2557039
[TBL] [Abstract][Full Text] [Related]
7. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
Bartoszek A; Konopa J
Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of nitroheterocyclic compounds, quinifuryl and nitracrine, towards leukaemic and normal cells on the dark and under illumination with visible light.
Daghastanli NA; Rossa MM; Selistre-De-Araujo HS; Tedesco AC; Borissevitch IE; Degterev IA
J Photochem Photobiol B; 2004 Jul; 75(1-2):27-32. PubMed ID: 15246347
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
Wilson WR; Thompson LH; Anderson RF; Denny WA
J Med Chem; 1989 Jan; 32(1):31-8. PubMed ID: 2909741
[TBL] [Abstract][Full Text] [Related]
10. Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
Stallings WC; Glusker JP; Carrell HL; Bogucka-Ledóchowska M; Ledóchowski A; Stezowski JJ
J Biomol Struct Dyn; 1984 Dec; 2(3):511-24. PubMed ID: 6400911
[TBL] [Abstract][Full Text] [Related]
11. Crosslinking of cellular DNA by nitracrine and furocoumarin derivatives.
Studzian K; Tołwińska-Stańczyk Z; Wilmańska D; Palumbo M; Gniazdowski M
Neoplasma; 1999; 46(1):50-3. PubMed ID: 10355534
[TBL] [Abstract][Full Text] [Related]
12. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.
Pawlak JW; Pawlak K; Konopa J
Chem Biol Interact; 1983 Feb; 43(2):151-73. PubMed ID: 6402314
[TBL] [Abstract][Full Text] [Related]
13. DNA-protein crosslinks induced in HeLa cells by bis-1-nitroacridines.
Pastwa E; Ciesielska E; Studzian K; Szmigiero L
Acta Biochim Pol; 1993; 40(1):69-71. PubMed ID: 8372570
[No Abstract] [Full Text] [Related]
14. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
15. Selective toxicity of nitracrine to hypoxic mammalian cells.
Wilson WR; Denny WA; Twigden SJ; Baguley BC; Probert JC
Br J Cancer; 1984 Feb; 49(2):215-23. PubMed ID: 6696822
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic activity of nitracrine derivatives in Salmonella typhimurium: relationship to drug physicochemical parameters, and to bacterial uvrB and recA genes and plasmid pKM101.
Ferguson LR; Denny WA; O'Rourke SM
Mutat Res; 1989 May; 223(1):13-22. PubMed ID: 2654627
[TBL] [Abstract][Full Text] [Related]
18. Anaerobic incubation and mutagenicity of nitracrine analogues in Salmonella typhimurium.
Ferguson LR; Roberton AM; Turner PM
Mutagenesis; 1987 Jul; 2(4):253-7. PubMed ID: 3325754
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
Seidenfeld J; Barnes D; Block AL; Erickson LC
Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720
[TBL] [Abstract][Full Text] [Related]
20. Effects of ledakrin on DNA and cell cycle in HeLa S3 cells.
Woynarowski JM; Konopa J
Drugs Exp Clin Res; 1986; 12(6-7):517-21. PubMed ID: 3743369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
